Navigation Links
NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
Date:5/16/2012

stained 24-hour bronchodilation over 52 weeks.

At Day 1, Week 26 and Week 52 of the GLOW2 study, NVA237 significantly improved lung function (measured by mean trough FEV1) compared to placebo (all p<0.001) and results were similar to those seen with OL tiotropium. At Day 1 and Week 12, 26 and 52, the FEV1 area under the curve (AUC) for 0-4 hr, 0-12 hr, 12-24 hr and 0-24 hr for NVA237 was superior to placebo (p<0.05) and numerically greater than OL tiotropium.

Shinichi Tamura, CEO of Sosei:

"GLOW2 data further illustrate the potential benefits of once daily NVA237 for patients with COPD. NVA237 has been submitted for approval in Europe and Japan and we look forward to a decision from EU regulators that is expected in 2012."

The study also demonstrated that NVA237 improved COPD symptoms, quality of life and reduced exacerbations compared to placebo. NVA237 significantly reduced breathlessness (measured by the transition dyspnea index or TDI, p=0.002), improved health-related quality of life (measured by the St George's Respiratory Questionnaire or SGRQ, p<0.001), reduced use of rescue medication (p=0.039), and increased the percentage of days with no daytime symptoms (p<0.05)compared to placebo over 52 weeks.

For these symptomatic and quality of life indicators, results were numerically similar to those observed with OL tiotropium over the same time period. NVA237 also significantly prolonged the time to first exacerbation and significantly reduced the rate of moderate/severe exacerbations versus placebo over 52 weeks (p=0.001); these effects were similar to OL tiotropium (p=0.001).

Throughout the GLOW2 study, NVA237 was well-tolerated with a similar incidence of adverse events to placebo and OL tiotropium. Serious adverse events were reported less frequently with NVA237 (12.6%) than with either placebo (15.4%) or OL tiotropium (15.0%).


'/>"/>

SOURCE Sosei Group Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
2. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
3. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
4. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
5. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
6. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
7. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
9. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
10. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015  Nevro Corp. (NYSE: ... and commercialized an innovative, evidence-based neuromodulation platform for the ... release financial results for the fourth quarter  and full ... 18, 2015. Company management will host a conference call ... Time) on Wednesday, March 18, 2015. ...
(Date:3/4/2015)... -- Mail-service and specialty pharmacies will save ... plans $11.8 billion over the next decade, according ... Association (PCMA). "Home delivery of traditional ... ways to reduce health costs," said PCMA President ... resist efforts to restrict these cost-saving tools." ...
(Date:3/4/2015)... , March 4, 2015 From ... attending the 2015 Distribution Management Conference and Expo ... conference is HDMA,s largest supply chain education event, ... third parties who keep the pharmaceutical distribution industry ... on regulatory and legislative issues important to healthcare ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2
... 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... months ended September 30, 2011. For the third quarter ... basic and diluted share, compared to a net income of ... share, respectively, in the same period of 2010. Basic weighted ...
... BEIJING, Nov. 1, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services ... CCM ), operator of the largest network of ... that it will hold its annual general meeting of ... time. The meeting will be held at its headquarters ...
Cached Medicine Technology:Rigel Announces Third Quarter 2011 Financial Results 2Rigel Announces Third Quarter 2011 Financial Results 3Rigel Announces Third Quarter 2011 Financial Results 4Rigel Announces Third Quarter 2011 Financial Results 5Concord Medical to Hold Annual General Meeting on November 26, 2011 2Concord Medical to Hold Annual General Meeting on November 26, 2011 3
(Date:3/4/2015)... When people talk about venues being the place to be ... the Houston Rodeo will be a name that ... livestock show and rodeo, one popular band will perform for ... at the event. The 2015 show will feature one of ... get the festival its largest attendance ever. , Houston Rodeo ...
(Date:3/4/2015)... WV (PRWEB) March 04, 2015 TROY ... (TSPE) software, which provides the ultimate level of security ... at the Hilton Houston Plaza Medical Center located at ... , Beginning at 7 AM, TROY Healthcare Solutions ... TROY Healthcare Solutions will offer brief presentations each hour ...
(Date:3/4/2015)... March 04, 2015 The ability ... in density assessment and help improve breast cancer ... abstracts accepted for presentation at the European Congress ... Ten abstracts - eight posters and 2 session ... automated breast density and quantitative breast imaging software ...
(Date:3/4/2015)... Blake’s All Natural Foods , ... attend this year’s Natural Products Expo West in Anaheim, ... this new line, Blake’s, who has the top four ... its commitment to creating high-quality dishes that are easily ... the natural channel, Blake’s understands what educated consumers are ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Vancouver ... recently received two awards in the prestigious Vancouver ... on February 27, 2015. The company secured third ... place in the “Best Registered Massage Therapist” category. ... community newspapers in Canada, The Vancouver Courier is ...
Breaking Medicine News(10 mins):Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2
... Institute for Tuberculosis and HIV (K-RITH) has awarded a ... South African scientists and students to help build new ... These are the first Collaborative Grants awarded by K-RITH, ... the University of KwaZulu-Natal (UKZN) and the Howard Hughes ...
... nuclear incident, researchers at Thomas Jefferson University ... an award to find novel drugs to treat people ... of a nuclear terrorist attack or a nuclear accident. ... given to six institutions under the National Institute ...
... 2011 The Translational Genomics Research Institute (TGen) has ... cancer tumors by modifying the actions of proteins. ... mission: To move laboratory discoveries more rapidly into therapeutics ... life. The drug, ONCO-101, is being licensed to ...
... May 4 (HealthDay News) -- Adults often find it hard ... about their wishes and hopes revealed some interesting trends, researchers ... 18, who completed a health screening questionnaire that included the ... be?" The researchers found that 85 percent of participants ...
... and the Management Sciences (INFORMS) will host its first ... 2011 takes place at the Hilton Bonaventure Hotel in ... range from improving the scheduling of patients at clinics ... for beaming radiation at cancer cells. , The conference ...
... News) -- Being sociable can help keep your brain healthy ... University Medical Center found that elderly people with the highest ... friends, going to parties or attending church -- showed much ... least socially active. The study included 1,138 ...
Cached Medicine News:Health News:K-RITH awards grants to foster teamwork among South African TB/HIV scientists 2Health News:Thomas Jefferson University and hospitals tasked to find new radiation drugs 2Health News:TGen licenses first drug for patient use in clinical care 2Health News:Simple Question Sheds Light on Teens' Hopes, Dreams 2Health News:Socializing May Keep Elderly Minds Sharp 2
... is intended for the quantitative determination of Erythropoietin ... for in vitro diagnostic use, as an aid ... the advent of the administration of recombinant erythropoietin ... cell mass, an erythropoietin assay may be used ...
Fully automated immunochemiluminometric assay for the rapid intraoperative,measurement of Intact PTH 1-84 using human serum or EDTA plasma....
Microwell EIA for the detection of EPO (Erythropoietin)...
Microwell IRMA for the detection of Intact PTH...
Medicine Products: